Related Experiment Video
Updated: Jun 26, 2026
09:23
Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
Nephrotoxicity of cadmium & lead
1Division of Nephrology, West Los Angeles Healthcare Center, Los Angeles, California 90073, USA. hgonick@ucla.edu
The Indian Journal of Medical Research
|December 25, 2008
Summary
Cadmium and lead cause kidney damage, but with distinct effects. Cadmium induces Fanconi syndrome, while lead causes gout and reduced glomerular filtration rate (GFR).
Area of Science:
- Toxicology
- Nephrology
- Environmental Health
Background:
- Cadmium and lead are divalent cations that accumulate in the kidney's proximal tubules, causing nephrotoxicity.
- The specific mechanisms and resulting pathologies of cadmium and lead nephrotoxicity differ significantly.
Purpose of the Study:
- To differentiate the distinct pathophysiological outcomes of cadmium and lead accumulation in the proximal tubule.
- To highlight the unique biomarkers and pathological features associated with each metal's nephrotoxicity.
Main Methods:
- Comparative analysis of clinical and pathological findings in cadmium and lead nephrotoxicity.
- Review of established literature on heavy metal-induced kidney damage.
Main Results:
- Cadmium exposure leads to Fanconi syndrome, characterized by proximal tubular reabsorptive defects and increased excretion of beta2-microglobulin, retinol binding protein, and alpha1-microglobulin.
- Lead exposure results in hyperuricemia, gout, diminished glomerular filtration rate (GFR), and absence of beta2-microglobulinuria. Early lead nephropathy shows nuclear inclusion bodies in proximal tubules.
- Albuminuria is variable in cadmium nephropathy but minimal or absent in lead nephropathy.
Conclusions:
- Cadmium and lead induce distinct forms of nephrotoxicity with different clinical presentations and biomarkers.
- Understanding these differences is crucial for accurate diagnosis and management of heavy metal-induced kidney disease.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...